Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice.

Drosatos K, Khan RS, Trent CM, Jiang H, Son NH, Blaner WS, Homma S, Schulze PC, Goldberg IJ.

Circ Heart Fail. 2013 May;6(3):550-62. doi: 10.1161/CIRCHEARTFAILURE.112.000177. Epub 2013 Apr 9.

PMID:
23572494
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.

Drosatos K, Drosatos-Tampakaki Z, Khan R, Homma S, Schulze PC, Zannis VI, Goldberg IJ.

J Biol Chem. 2011 Oct 21;286(42):36331-9. doi: 10.1074/jbc.M111.272146. Epub 2011 Aug 26.

PMID:
21873422
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.

Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, Homma S, Szabolcs MJ, Huang LS, Goldberg IJ.

J Clin Invest. 2007 Oct;117(10):2791-801.

PMID:
17823655
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.

Duncan JG, Bharadwaj KG, Fong JL, Mitra R, Sambandam N, Courtois MR, Lavine KJ, Goldberg IJ, Kelly DP.

Circulation. 2010 Jan 26;121(3):426-35. doi: 10.1161/CIRCULATIONAHA.109.888735. Epub 2010 Jan 11.

PMID:
20065164
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction.

Knuefermann P, Nemoto S, Misra A, Nozaki N, Defreitas G, Goyert SM, Carabello BA, Mann DL, Vallejo JG.

Circulation. 2002 Nov 12;106(20):2608-15.

PMID:
12427659
[PubMed - indexed for MEDLINE]
Free Article
7.

Exposure to rosiglitazone, a PPAR-γ agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus.

Lie S, Hui M, McMillen IC, Muhlhausler BS, Posterino GS, Dunn SL, Wang KC, Botting KJ, Morrison JL.

Am J Physiol Regul Integr Comp Physiol. 2014 Mar 15;306(6):R429-37. doi: 10.1152/ajpregu.00431.2013. Epub 2014 Jan 29.

PMID:
24477540
[PubMed - indexed for MEDLINE]
8.

Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.

Pellieux C, Montessuit C, Papageorgiou I, Lerch R.

Pflugers Arch. 2007 Dec;455(3):443-54. Epub 2007 Jul 21.

PMID:
17643263
[PubMed - indexed for MEDLINE]
9.

Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model.

Lee S, Kim W, Kang KP, Moon SO, Sung MJ, Kim DH, Kim HJ, Park SK.

Nephrol Dial Transplant. 2005 Jun;20(6):1057-65. Epub 2005 Mar 29.

PMID:
15797891
[PubMed - indexed for MEDLINE]
Free Article
10.

Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.

Schilling J, Lai L, Sambandam N, Dey CE, Leone TC, Kelly DP.

Circ Heart Fail. 2011 Jul;4(4):474-82. doi: 10.1161/CIRCHEARTFAILURE.110.959833. Epub 2011 May 10.

PMID:
21558447
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, Plutzky J.

J Am Coll Cardiol. 2008 Sep 2;52(10):869-81. doi: 10.1016/j.jacc.2008.04.055. Epub 2008 Jul 2.

PMID:
18755353
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.

Aleshin S, Grabeklis S, Hanck T, Sergeeva M, Reiser G.

Mol Pharmacol. 2009 Aug;76(2):414-24. doi: 10.1124/mol.109.056010. Epub 2009 May 29.

PMID:
19483106
[PubMed - indexed for MEDLINE]
Free Article
13.

Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.

Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL, Clarke K, Berge RK, Aasum E.

Cardiovasc Res. 2009 Aug 1;83(3):519-26. doi: 10.1093/cvr/cvp132. Epub 2009 Apr 27.

PMID:
19398469
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.

Barbieri M, Di Filippo C, Esposito A, Marfella R, Rizzo MR, D'Amico M, Ferraraccio F, Di Ronza C, Duan SZ, Mortensen RM, Rossi F, Paolisso G.

PLoS One. 2012;7(4):e35999. doi: 10.1371/journal.pone.0035999. Epub 2012 Apr 26.

PMID:
22563432
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.

Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold KR.

Metabolism. 2007 Feb;56(2):267-79.

PMID:
17224343
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.

Takano H, Nagai T, Asakawa M, Toyozaki T, Oka T, Komuro I, Saito T, Masuda Y.

Circ Res. 2000 Sep 29;87(7):596-602.

PMID:
11009565
[PubMed - indexed for MEDLINE]
Free Article
17.

Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.

Planavila A, Sánchez RM, Merlos M, Laguna JC, Vázquez-Carrera M.

Biochim Biophys Acta. 2005 Sep 15;1736(2):120-7.

PMID:
16139565
[PubMed - indexed for MEDLINE]
Free Article
19.

Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.

Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA.

Diabetes. 2008 Sep;57(9):2470-9. doi: 10.2337/db07-0924. Epub 2008 May 28.

PMID:
18511847
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury.

Reddy AT, Lakshmi SP, Kleinhenz JM, Sutliff RL, Hart CM, Reddy RC.

J Immunol. 2012 Dec 1;189(11):5411-20. doi: 10.4049/jimmunol.1201487. Epub 2012 Oct 26.

PMID:
23105142
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk